The Open University
The role of the immune microenvironment in inducing local and abscopal effects after radiotherapy combined with TLR agonists
Abstract
dc:description.abstractImmunotherapy has notably improved cancer therapy. However, some patients still do not respond, necessitating new therapeutic approaches. Radiotherapy (RT) has both immuno-suppressive and immuno- stimulatory functions. Besides local effects, elicited anti-tumour immunity could mediate the regression of untreated metastases, an effect called “abscopal”. To boost this response, combining RT- and immuno- therapy could be a promising strategy. We evaluated the efficacy of local administration of two different toll-like receptor (TLR) agonists in combination with fractionated RT in mouse models of head and neck squamous cell cancer (HNSCC) and prostate cancer (PCa). In order to study the abscopal effect, mice were challenged on both flanks with tumour cells, but only the left lesion was treated. At the end of the experiments, the immune microenvironment was analysed through flow cytometry, immunohistochemistry (IHC) and/or digital spatial profiling (DSP). Our data show that in the HNSCC model, MOC1, both TLR9 and TLR3 agonists, given as single agents, were able to reduce the growth of the treated lesion and, slightly, also of the contralateral, untreated tumour mass, without any additive effect given by the combination with RT. Treatment with the TLR9 agonist also reprogrammed the tumour microenvironment (TME), reducing the frequency of immunosuppressive myeloid populations in both treated and untreated lesions. On the contrary, in PCa the TLR9 agonist was ineffective, whereas we observed a strong anti-tumour activity of the TLR3 agonist, on treated lesions in three different models (T23, RM1, ST4787). Combination of the TLR3 agonist with RT had no apparent additive effect on volume reduction. Yet, despite similar tumour size, the TME composition was significantly different in both treated and contralateral lesions in all three PCa models. DSP and IHC analyses revealed the formation of putative tertiary lymphoid structures (TLS) in PCa tumours locally treated with the TLR3 agonist and RT. This result was also reinforced by flow cytometry, which showed an increase of CD8+ T cells and germinal centre B cells within the treated tumour lesions, in all three 11 PCa models. We also observed a slight abscopal effect in these mice. Finally, survival experiments in the PCa models showed a superior benefit of the combination of TLR3 agonist and RT over the other treatment groups. These data support the hypothesis that combining local RT with TLR agonists can improve the anti-tumour immune response. They also suggest that different molecular mechanisms could be involved in the observed therapeutic effects in the different cancer models. Further studies are needed to endorse the results and to dissect in depth the immune-mediated mechanisms behind the therapeutic effects.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Fischetti, Irene
Rights
- Language dc:language
- en